Overview
Michael Oellerich practices in Goettingen, Germany. Mr. Oellerich is rated as an Experienced expert by MediFind in the treatment of Acute Tubular Necrosis. His top areas of expertise are HELLP Syndrome, Allergic Bronchopulmonary Aspergillosis, Acute Tubular Necrosis, Kidney Transplant, and Liver Transplant.
His clinical research consists of co-authoring 79 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Acute Tubular Necrosis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- HELLP SyndromeMr. Oellerich isAdvanced. Learn about HELLP Syndrome.
- Kidney TransplantMr. Oellerich isAdvanced. Learn about Kidney Transplant.
- Liver TransplantMr. Oellerich isAdvanced. Learn about Liver Transplant.
- Experienced
- Acute Tubular NecrosisMr. Oellerich isExperienced. Learn about Acute Tubular Necrosis.
- Allergic Bronchopulmonary AspergillosisMr. Oellerich isExperienced. Learn about Allergic Bronchopulmonary Aspergillosis.
- AspergillosisMr. Oellerich isExperienced. Learn about Aspergillosis.
- Chronic Kidney DiseaseMr. Oellerich isExperienced. Learn about Chronic Kidney Disease.
- EGFR Positive Lung CancerMr. Oellerich isExperienced. Learn about EGFR Positive Lung Cancer.
- GlomerulonephritisMr. Oellerich isExperienced. Learn about Glomerulonephritis.